After touting “positive results” in December and August for its Phase III cancer drug, Odonate Therapeutics is now discontinuing drug development and closing up shop.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,